cardiovascular system
N |
• no (ultra)structural abnormalities
• no ventricular dilatation nor pulmonary congestion
• no difference in QRS duration or QT or PQ interval
• no difference in spontaneous or induced arrhythmias (neither ventricular nor atrial) nor in AV nodal conduction
|
• significantly increased cardiomyocyte surface area after transverse aortic constriction (TAC)
|
• exaggerated increase in heart weight, heart weight to body weight ratio and ventricular weight to body weight ratio after transverse aortic constriction (TAC)
|
• exaggerated increase in heart size after transverse aortic constriction (TAC)
|
• after transverse aortic constriction (TAC)
|
• after transverse aortic constriction (TAC)
|
muscle
• significantly increased cardiomyocyte surface area after transverse aortic constriction (TAC)
|
• after transverse aortic constriction (TAC)
|
mortality/aging
N |
• viable and normal lifespan
|
• significantly increased mortality rate after transverse aortic constriction (TAC)
|
nervous system
• significantly shorter ventricular action potential durations at paced cycle length of 100200 ms
|
respiratory system
• pronounced increase in lung weight to body weight ratio after transverse aortic constriction (TAC)
|
reproductive system
N |
• fertile
|
growth/size/body
• exaggerated increase in heart weight, heart weight to body weight ratio and ventricular weight to body weight ratio after transverse aortic constriction (TAC)
|
• exaggerated increase in heart size after transverse aortic constriction (TAC)
|
• pronounced increase in lung weight to body weight ratio after transverse aortic constriction (TAC)
|